Greedy Insider · Filing
INM · Buy · ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC (10% owner) bought 2,640 shares of InMed Pharmaceuticals Inc. (INM) at $13.10, about $35K, on Nov 5, 2026, filed with the SEC on Nov 10, 2026.
Greediness Score 42 · Mixed · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001940272-26-000031